Prior investigations have suggested that the classical m7G writer METTL1 may undergo transcriptional upregulation by the transcription factor (TF) SP1, thereby stabilizes CDK14 mRNA and contributes to the progression of prostate cancers 53. Here, METTL1 is linked to prostate cancer.